How to taper citalopram (Celexa) while starting fluoxetine (Prozac)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How to Taper Citalopram While Starting Fluoxetine

Gradually taper citalopram by reducing the dose by 25% of the current dose every 1-2 weeks until reaching the lowest available dose (typically 10 mg), then start fluoxetine at 10 mg every other morning after citalopram is completely discontinued or at a very low dose. 1

Citalopram Tapering Protocol

Reduction Schedule

  • Reduce citalopram by 25% of the current dose every 1-2 weeks (for example: 40 mg → 30 mg → 22.5 mg → 17 mg → 12.5 mg → 10 mg) 1
  • Continue tapering until reaching the lowest available dose, typically 10 mg for citalopram 1
  • The taper rate must be determined by the patient's ability to tolerate reductions, not by a rigid schedule 2

Managing Withdrawal Symptoms

  • If withdrawal symptoms occur (dizziness, nausea, fatigue, anxiety, sensory disturbances), slow the taper rate or temporarily return to the previous dose until symptoms subside 1, 3
  • Withdrawal symptoms should be preempted and treated with liberal use of adjuvant agents (such as trazodone for insomnia) along with adequate clinician support 1
  • Gradual tapering is necessary for all SSRIs except fluoxetine, which has an extended half-life 3

Important Considerations for SSRI Tapering

  • Studies show that hyperbolic (exponential) tapering down to doses much lower than minimum therapeutic doses has shown greater success in reducing withdrawal symptoms compared to standard short tapers 4
  • Withdrawal symptoms frequently emerge after abrupt discontinuation and are generally mild and self-limiting but can be distressing and lead to missed work days 3
  • Symptoms may be somatic (dizziness, nausea, fatigue, flu-like symptoms, sensory disturbances) or psychological (anxiety, irritability, crying spells) 3

Initiating Fluoxetine

Starting Dose and Timing

  • Start fluoxetine at 10 mg every other morning after citalopram is completely discontinued or at a very low dose 1
  • Fluoxetine's very long half-life (4-6 days for the active metabolite) makes it less likely to cause withdrawal symptoms when eventually discontinued 1
  • Increase fluoxetine gradually as needed up to 20 mg every morning 1

Monitoring for Side Effects

  • Monitor for activation, nervousness, insomnia, and gastrointestinal disturbances 1
  • Avoid starting fluoxetine at too high a dose, which may increase side effects 1

Monitoring During Transition

Follow-Up Schedule

  • Schedule more frequent follow-up appointments during the tapering and switching period 1
  • Follow up at least monthly during the taper, and more frequent contact may be needed during difficult phases 2
  • Monitor for withdrawal symptoms, mood changes, and suicidal ideation 2
  • Assess for return of original symptoms (depression/anxiety) and emergence of withdrawal symptoms 1

Common Pitfalls to Avoid

  • Do not mistake withdrawal symptoms for relapse into depression, which may lead to unnecessary treatment changes 3
  • Do not taper too quickly—standard 2-4 week tapers show minimal benefits over abrupt discontinuation and are often not tolerated 4
  • Pauses in the taper are acceptable and often necessary when withdrawal symptoms emerge 2

Special Considerations

Why Fluoxetine is Advantageous for Switching

  • Fluoxetine's extended half-life provides a "self-tapering" effect that minimizes withdrawal risk when eventually discontinued 1, 3
  • This makes fluoxetine particularly useful as a destination SSRI when switching from shorter half-life agents like citalopram 3

Patient Education

  • Educate patients that withdrawal symptoms are usually transient and not dangerous 3
  • Reassure patients that mild symptoms can often be managed with simple reassurance 3
  • Advise patients to report any concerning symptoms promptly rather than stopping medications abruptly 1

References

Guideline

Tapering Sertraline and Switching to Fluoxetine

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Benzodiazepine Discontinuation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Clinical management of antidepressant discontinuation.

The Journal of clinical psychiatry, 1997

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.